Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 1
1994 1
1995 3
1996 1
1997 1
1998 1
2000 2
2001 3
2002 6
2003 2
2004 2
2005 2
2006 17
2007 9
2008 9
2009 13
2010 21
2011 24
2012 22
2013 16
2014 22
2015 22
2016 29
2017 19
2018 38
2019 42
2020 52
2021 42
2022 38
2023 43
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

451 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Familial hemophagocytic lymphohistiocytosis 5"
Page 1
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.
Keenan C, Nichols KE, Albeituni S. Keenan C, et al. Front Immunol. 2021 Feb 16;12:614704. doi: 10.3389/fimmu.2021.614704. eCollection 2021. Front Immunol. 2021. PMID: 33664745 Free PMC article. Review.
Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome driven by overactive T cells and macrophages that abundantly secrete numerous pro-inflammatory cytokines, including interferon (IFN)-gamma, interleukin (IL)-1-beta, IL-2, IL-6, IL-10, IL-1 …
Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome driven by overactive T cells and macrophages tha …
Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
Knaak C, Nyvlt P, Schuster FS, Spies C, Heeren P, Schenk T, Balzer F, La Rosée P, Janka G, Brunkhorst FM, Keh D, Lachmann G. Knaak C, et al. Crit Care. 2020 May 24;24(1):244. doi: 10.1186/s13054-020-02941-3. Crit Care. 2020. PMID: 32448380 Free PMC article.
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare though often fatal hyperinflammatory syndrome mimicking sepsis in the critically ill. ...Receiver operating characteristics (ROC) analysis was performed to determine prediction accuracy. RESULTS: …
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare though often fatal hyperinflammatory syndrome mimicking sepsis …
Familial Hemophagocytic Lymphohistiocytosis.
Degar B. Degar B. Hematol Oncol Clin North Am. 2015 Oct;29(5):903-13. doi: 10.1016/j.hoc.2015.06.008. Epub 2015 Aug 25. Hematol Oncol Clin North Am. 2015. PMID: 26461150 Review.
Familial hemophagocytic lymphohistiocytosis (FHL) is a rare heritable disorder of immune regulation that is typically characterized by sudden onset of severe systemic illness. ...
Familial hemophagocytic lymphohistiocytosis (FHL) is a rare heritable disorder of immune regulation that is typically c …
Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment.
Carter SJ, Tattersall RS, Ramanan AV. Carter SJ, et al. Rheumatology (Oxford). 2019 Jan 1;58(1):5-17. doi: 10.1093/rheumatology/key006. Rheumatology (Oxford). 2019. PMID: 29481673 Review.
Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome, which if not promptly treated, can lead rapidly to critical illness and death. ...In this review we highlight the pathogenesis of MAS/sHLH including its underlying triggers, key clinical features an …
Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome, which if not promptly treated, can lead rapidly to critica …
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.
Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI; Histiocyte Society. Trottestam H, et al. Blood. 2011 Oct 27;118(17):4577-84. doi: 10.1182/blood-2011-06-356261. Epub 2011 Sep 6. Blood. 2011. PMID: 21900192 Free PMC article. Clinical Trial.
Hemophagocytic lymphohistiocytosis (HLH) used to have a dismal prognosis. ...In 124 patients who underwent HSCT, 5-year survival was 66 8%; tendency to increased survival (P = .064) in patients with nonactive disease at HSCT. Patients with familial dis …
Hemophagocytic lymphohistiocytosis (HLH) used to have a dismal prognosis. ...In 124 patients who underwent HSCT, 5-year …
The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami S, Vagrecha A, Soberman D, Badawi M, Cannone D, Lipton JM, Cron RQ, Levy CF. Bami S, et al. Pediatr Blood Cancer. 2020 Nov;67(11):e28581. doi: 10.1002/pbc.28581. Epub 2020 Jul 29. Pediatr Blood Cancer. 2020. PMID: 32725881
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) can be familial or secondary, which is often triggered by infection or malignancy. ...
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) can be familial or secondary, which is often triggered by infectio …
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.
Zhang Q, Zhu L, Zhou D, Li L, Xie W, Tan Y, Ye X. Zhang Q, et al. Ann Hematol. 2023 Sep;102(9):2301-2308. doi: 10.1007/s00277-023-05153-1. Epub 2023 Jun 2. Ann Hematol. 2023. PMID: 37266671
The aim of our study was to summarize the clinical characteristics of early death patients with newly diagnosed secondary hemophagocytic lymphohistiocytosis (sHLH), analyze the risk factors of early death, and analyze the survival of patients. ...
The aim of our study was to summarize the clinical characteristics of early death patients with newly diagnosed secondary hemophagocytic …
Hemophagocytic Lymphohistiocytosis in Adults.
Campo M, Berliner N. Campo M, et al. Hematol Oncol Clin North Am. 2015 Oct;29(5):915-25. doi: 10.1016/j.hoc.2015.06.009. Epub 2015 Aug 14. Hematol Oncol Clin North Am. 2015. PMID: 26461151 Review.
Hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal syndrome of pathologic immune dysregulation characterized by clinical signs and symptoms of extreme inflammation. ...
Hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal syndrome of pathologic immune dysregulation character …
The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
Zhang J, Qin S, Jin Z, Chen Q, Xing L, Qiu T, Xia Y, Liang J, Zhu H, Wang L, Fan L, Xu W, Li J, Miao Y. Zhang J, et al. J Clin Immunol. 2023 Aug;43(6):1302-1310. doi: 10.1007/s10875-023-01493-9. Epub 2023 Apr 24. J Clin Immunol. 2023. PMID: 37093406
PURPOSE: To evaluate the role of circulating Epstein-Barr virus (EBV) DNA in lymphoma-associated hemophagocytic lymphohistiocytosis (HLH). METHODS: We conducted a retrospective cohort study to explore the clinical and prognostic significance of EBV DNA in lym …
PURPOSE: To evaluate the role of circulating Epstein-Barr virus (EBV) DNA in lymphoma-associated hemophagocytic lymphohistiocytosi …
Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis.
Song Y, Li X, He X, Zhou F, Du F, Wang Z, Chen S, Wu D. Song Y, et al. Front Immunol. 2023 Jun 29;14:1211655. doi: 10.3389/fimmu.2023.1211655. eCollection 2023. Front Immunol. 2023. PMID: 37457729 Free PMC article. Clinical Trial.
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a severe disorder characterized by excessive secretion of cytokines. ...The area of sCD25 under the ROC curve was 0.8125 (95% CI 0.5921 to 1.033, p=0.035) when using 10,000 pg/ml as the cut-off value for pre …
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a severe disorder characterized by excessive secretion of cytokines. . …
451 results